AMI Aesthetic Laser Technical Brief October 2, 2026
This was a light week for credible peer-reviewed service research. These three items were the most actionable; I excluded generic maintenance and marketing articles.
1. Clarity II sparking reports reveal an important diagnostic trap
Newly surfaced FDA MAUDE reports describe Clarity II units sparking during treatment, with one blister and one burn reported. The events involved ICD 10/10/10 settings and possible use of an older red-lid cryogen canister. However, field engineers could not reproduce the malfunction, and the tested Alex/YAG output, handpiece, fiber, and cartridges were reportedly within specification. The manufacturer stated that the cause remained inconclusive.
What changed: These reports add consumable compatibility and intermittent treatment-condition factors to the Clarity II sparking investigation—not just damaged optics or low/out-of-spec energy.
Why it matters: A unit can pass a conventional energy check after a serious intermittent event. “Operating within specification” does not necessarily explain or close a spark/pop complaint.
Practical takeaway: For Clarity II spark complaints, document:
- Cryogen canister type and lid color
- ICD settings, wavelength, spot size and fluence
- Handpiece window and cartridge condition
- Fiber condition and measured Alex/YAG output
Do not assume the older cryogen caused the event the FDA reports specifically say the connection was undetermined. Escalate repeated sparking even if bench testing passes.
2. Counterfeit Alma Soprano systems found in operating clinics
Health Canada reported that counterfeit diode hair-removal and therapy systems carrying the Soprano name had been advertised and sold to clinics. The units identified Beijing Perfectlaser Technology as the manufacturer and were supported by a falsified medical-device licence; Alma confirmed they were counterfeit.
What changed: Counterfeit systems are no longer only a used-equipment marketplace concern regulators found them in clinics represented as authorized Soprano devices.
Why it matters: A counterfeit chassis may have undocumented power supplies, cooling circuits, software, interlocks and handpiece pinouts. Standard Alma service assumptions and parts should not automatically be applied.
Practical takeaway: Add an authenticity check before accepting Soprano equipment for service or trade-in:
- Photograph the permanent nameplate.
- Record manufacturer, exact model, catalogue number and serial number.
- Compare the information with regulatory listings and available Alma records.
- Place questionable units on hold before test-firing, connecting genuine handpieces or ordering parts.
3. FDA laser-equipment standard transition clarified
The FDA’s laser-equipment standards record, updated September 28, states that IEC 60601-2-22 Edition 3.1 is being superseded by Edition 4.0. FDA will continue accepting declarations to Edition 3.1 for premarket submissions only through July 4, 2027. The standard covers essential performance and basic safety for Class 3B and Class 4 medical, cosmetic and therapeutic laser equipment.
What changed: There is now a clear transition deadline for the older edition.
Why it matters: This primarily affects manufacturers and regulatory submissions, but it also signals that service companies should review whether acceptance-testing, safety-check and modification documentation still relies exclusively on the older edition.
Practical takeaway: Record the applicable safety-standard edition from each machine’s labeling and technical documentation. Avoid claiming that a repaired or modified system “meets the latest IEC standard” unless that conclusion is supported by appropriate testing and documentation.
AMI shop priority: Circulate the Clarity II diagnostic note immediately and add the Soprano identity check to used-device intake. The strongest lesson this week is that passing output tests alone does not rule out an intermittent treatment-path failure.